A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.

R.J. Van Geest; S.Y. Lesnik-Oberstein; H.S. Tan; M. Mura; R. Goldschmeding; C.J. Van Noorden; I. Klaassen; R.O. Schlingemann

doi:10.1136/bjophthalmol-2011-301005

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.

R.J. Van Geest, S.Y. Lesnik-Oberstein, H.S. Tan, M. Mura, R. Goldschmeding, C.J. Van Noorden, I. Klaassen, R.O. Schlingemann

NIN

Onderzoeksoutput: Bijdrage aan wetenschappelijk tijdschrift/periodieke uitgave › Artikel › Wetenschappelijk › peer review

Originele taal-2	Engels
Pagina's (van-tot)	587-590
Tijdschrift	British Journal of Ophthalmology
Volume	96
DOI's	https://doi.org/10.1136/bjophthalmol-2011-301005
Status	Gepubliceerd - 2012

Toegang tot document

10.1136/bjophthalmol-2011-301005

Citeer dit

Van Geest, R. J., Lesnik-Oberstein, S. Y., Tan, H. S., Mura, M., Goldschmeding, R., Van Noorden, C. J., Klaassen, I., & Schlingemann, R. O. (2012). A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. British Journal of Ophthalmology, 96, 587-590. https://doi.org/10.1136/bjophthalmol-2011-301005

Van Geest, R.J. ; Lesnik-Oberstein, S.Y. ; Tan, H.S. ; Mura, M. ; Goldschmeding, R. ; Van Noorden, C.J. ; Klaassen, I. ; Schlingemann, R.O. / A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. In: British Journal of Ophthalmology. 2012 ; Vol. 96. blz. 587-590.

@article{9f63f17de52240d581864779ed3c0edd,

title = "A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.",

author = "{Van Geest}, R.J. and S.Y. Lesnik-Oberstein and H.S. Tan and M. Mura and R. Goldschmeding and {Van Noorden}, C.J. and I. Klaassen and R.O. Schlingemann",

note = "Reporting year: 2012",

year = "2012",

doi = "10.1136/bjophthalmol-2011-301005",

language = "English",

volume = "96",

pages = "587--590",

journal = "British Journal of Ophthalmology",

issn = "0007-1161",

publisher = "BMJ Publishing Group",

}

Van Geest, RJ, Lesnik-Oberstein, SY, Tan, HS, Mura, M, Goldschmeding, R, Van Noorden, CJ, Klaassen, I & Schlingemann, RO 2012, 'A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.', British Journal of Ophthalmology, vol. 96, blz. 587-590. https://doi.org/10.1136/bjophthalmol-2011-301005

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. / Van Geest, R.J.; Lesnik-Oberstein, S.Y.; Tan, H.S.; Mura, M.; Goldschmeding, R.; Van Noorden, C.J.; Klaassen, I.; Schlingemann, R.O.

In: British Journal of Ophthalmology, Vol. 96, 2012, blz. 587-590.

Onderzoeksoutput: Bijdrage aan wetenschappelijk tijdschrift/periodieke uitgave › Artikel › Wetenschappelijk › peer review

TY - JOUR

T1 - A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.

AU - Van Geest, R.J.

AU - Lesnik-Oberstein, S.Y.

AU - Tan, H.S.

AU - Mura, M.

AU - Goldschmeding, R.

AU - Van Noorden, C.J.

AU - Klaassen, I.

AU - Schlingemann, R.O.

N1 - Reporting year: 2012

PY - 2012

Y1 - 2012

U2 - 10.1136/bjophthalmol-2011-301005

DO - 10.1136/bjophthalmol-2011-301005

M3 - Article

VL - 96

SP - 587

EP - 590

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

ER -

Van Geest RJ, Lesnik-Oberstein SY, Tan HS, Mura M, Goldschmeding R, Van Noorden CJ et al. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. British Journal of Ophthalmology. 2012;96:587-590. https://doi.org/10.1136/bjophthalmol-2011-301005